• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

LPYC225混合物对感染细菌性阴道病的小鼠阴道细菌群落有部分调节作用。

LPYC225 mixture partially modulates the vaginal bacterial community of -infected bacterial vaginosis in mice.

作者信息

Kim Hyun Ju, Kim Dong-Gu, Kang Sa-Haeng, Choi Hoonsung, Go Se-Woong, Kim Dong-Keun, Myung Je-Hun, Park Jeong-Hyang, Soh Ju-Ryoun, Kim Suk-Kyu, Hong Sung Wook, Kang Miran, Park Eui-Seong, Park Ilbum, Kang Jongsoo, Kwon Hyuk Ju, Jin Jong-Sik

机构信息

Present Address: Miran Kang-Kimchi Industry Promotion Division, World Institute of Kimchi, Gwangju, 61755 Republic of Korea.

Departments of Korean Medicine, Dong-eui University, Busan, 47340 Republic of Korea.

出版信息

Food Sci Biotechnol. 2024 Jul 4;33(9):2233-2242. doi: 10.1007/s10068-024-01641-w. eCollection 2024 Jul.

DOI:10.1007/s10068-024-01641-w
PMID:39130651
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11315855/
Abstract

UNLABELLED

Bacterial vaginosis (BV) is defined as dysbiosis of the vaginal microbiome associated with the depletion of and excessive growth of commensal or pathogenic bacteria. This study investigated the effects of lactic acid bacteria (LAB) mixture (LM; InoRexyne™) on the vaginal bacterial community of ()-infected BV mice. Single LAB and LM exhibited antibacterial and anti-inflammatory effects by inhibiting growth and pro-inflammatory markers in RAW 264.7 cells. Administering LM did not significantly alter the vaginal architecture or fecal short-chain fatty acids but did significantly inhibit the vaginal interleukin-6 levels in the high LM group compared to the GV group. LM administration decreased the relative abundances of , and in vaginal flushing fluids compared to the GV group. LM partially alleviated BV by inhibiting growth and modulating the vaginal bacterial community, providing new insights into its modulatory effects on the vaginal microbiome in BV.

SUPPLEMENTARY INFORMATION

The online version contains supplementary material available at 10.1007/s10068-024-01641-w.

摘要

未标注

细菌性阴道病(BV)被定义为阴道微生物群的生态失调,与共生菌或病原菌的减少和过度生长有关。本研究调查了乳酸菌(LAB)混合物(LM;InoRexyne™)对感染()的BV小鼠阴道细菌群落的影响。单一LAB和LM通过抑制RAW 264.7细胞中的生长和促炎标志物表现出抗菌和抗炎作用。与GV组相比,给予LM对阴道结构或粪便短链脂肪酸没有显著影响,但在高LM组中显著抑制了阴道白细胞介素-6水平。与GV组相比,给予LM可降低阴道冲洗液中、和的相对丰度。LM通过抑制生长和调节阴道细菌群落部分缓解了BV,为其对BV阴道微生物群的调节作用提供了新的见解。

补充信息

在线版本包含可在10.1007/s10068-024-01641-w获取的补充材料。

相似文献

1
LPYC225 mixture partially modulates the vaginal bacterial community of -infected bacterial vaginosis in mice.LPYC225混合物对感染细菌性阴道病的小鼠阴道细菌群落有部分调节作用。
Food Sci Biotechnol. 2024 Jul 4;33(9):2233-2242. doi: 10.1007/s10068-024-01641-w. eCollection 2024 Jul.
2
Effect of the vaginal live biotherapeutic LACTIN-V (Lactobacillus crispatus CTV-05) on vaginal microbiota and genital tract inflammation among women at high risk of HIV acquisition in South Africa: a phase 2, randomised, placebo-controlled trial.阴道活性生物治疗剂LACTIN-V(卷曲乳杆菌CTV-05)对南非艾滋病病毒感染高危女性阴道微生物群和生殖道炎症的影响:一项2期随机安慰剂对照试验。
Lancet Microbe. 2025 Apr 3:101037. doi: 10.1016/j.lanmic.2024.101037.
3
IL-33 Participates in -Induced Bacterial Vaginosis: Involvement of Intravaginal IgA.白细胞介素-33参与诱导细菌性阴道病:阴道内免疫球蛋白A的作用
J Inflamm Res. 2025 Jun 17;18:8005-8013. doi: 10.2147/JIR.S523880. eCollection 2025.
4
Temporal dynamics of the vaginal microbiome and host immune markers before, during, and after metronidazole treatment for bacterial vaginosis.甲硝唑治疗细菌性阴道病之前、期间及之后阴道微生物群和宿主免疫标志物的时间动态变化
mSystems. 2025 Jul 3:e0038025. doi: 10.1128/msystems.00380-25.
5
Syntrophic bacterial and host-microbe interactions in bacterial vaginosis.细菌性阴道病中的互养细菌与宿主-微生物相互作用
ISME J. 2025 Jan 2;19(1). doi: 10.1093/ismejo/wraf055.
6
Alterations in vaginal microbiome in women with short cervix: longitudinal study of microbial diversity and impact of vaginal progesterone treatment.宫颈短的女性阴道微生物群的改变:微生物多样性的纵向研究及阴道孕酮治疗的影响
Ultrasound Obstet Gynecol. 2025 Jun 26. doi: 10.1002/uog.29269.
7
Vaginal pharmacomicrobiomics modulates risk of persistent and recurrent bacterial vaginosis.阴道药物微生物组学调节持续性和复发性细菌性阴道病的风险。
NPJ Biofilms Microbiomes. 2025 Jul 1;11(1):115. doi: 10.1038/s41522-025-00748-0.
8
Effectiveness of the two microorganisms Lactobacillus fermentum LF15 and Lactobacillus plantarum LP01, formulated in slow-release vaginal tablets, in women affected by bacterial vaginosis: a pilot study.两种微生物发酵乳杆菌LF15和植物乳杆菌LP01制成缓释阴道片,对患有细菌性阴道病的女性的有效性:一项试点研究。
J Clin Gastroenterol. 2014 Nov-Dec;48 Suppl 1:S106-12. doi: 10.1097/MCG.0000000000000226.
9
Contribution of to Vaginal Health and Diseases: A Systematic Review.关于 在阴道健康和疾病中的作用:系统评价。
Front Cell Infect Microbiol. 2021 Nov 22;11:792787. doi: 10.3389/fcimb.2021.792787. eCollection 2021.
10
Lactobacilli Strain Mixture Alleviates Bacterial Vaginosis through Antibacterial and Antagonistic Activity in -Infected C57BL/6 Mice.乳酸杆菌菌株混合物通过对感染的C57BL/6小鼠的抗菌和拮抗活性减轻细菌性阴道病。
Microorganisms. 2022 Feb 20;10(2):471. doi: 10.3390/microorganisms10020471.

引用本文的文献

1
The inferred modulation of correlated vaginal microbiota and metabolome by cervical differentially expressed genes across distinct CIN grades.不同CIN分级中宫颈差异表达基因对相关阴道微生物群和代谢组的推断调控。
BMC Microbiol. 2025 Apr 2;25(1):189. doi: 10.1186/s12866-025-03922-8.
2
The Promising Biological Role of Postbiotics in Treating Human Infertility.后生元在治疗人类不孕症中的潜在生物学作用。
Probiotics Antimicrob Proteins. 2025 Jan 30. doi: 10.1007/s12602-025-10458-w.

本文引用的文献

1
Thymus Vulgaris Oil Nanoemulsion: Synthesis, Characterization, Antimicrobial and Anticancer Activities.普通百里香油纳米乳的合成、表征及抗菌和抗癌活性。
Molecules. 2023 Oct 2;28(19):6910. doi: 10.3390/molecules28196910.
2
Probiotics Improve Vaginal Dysbiosis in Asymptomatic Women.益生菌可改善无症状女性的阴道菌群失调。
Nutrients. 2023 Apr 13;15(8):1862. doi: 10.3390/nu15081862.
3
Bacterial Vaginosis-Vaginal Polymicrobial Biofilms and Dysbiosis.细菌性阴道病-阴道多微生物生物膜和微生态失调。
Dtsch Arztebl Int. 2023 May 19;120(20):347-354. doi: 10.3238/arztebl.m2023.0090.
4
Use of probiotic lactobacilli in the treatment of vaginal infections: and investigations.应用益生菌乳杆菌治疗阴道感染:临床和实验研究。
Front Cell Infect Microbiol. 2023 Apr 3;13:1153894. doi: 10.3389/fcimb.2023.1153894. eCollection 2023.
5
HY7801 ameliorates bacterial vaginosis by inhibiting biofilm formation and epithelial cell adhesion of .HY7801通过抑制生物膜形成和……的上皮细胞黏附来改善细菌性阴道病。 (原文中“of”后面内容缺失)
Food Sci Biotechnol. 2022 Dec 1;32(4):507-515. doi: 10.1007/s10068-022-01208-7. eCollection 2023 Mar.
6
, a Potent Probiotic, Alleviates Colitis via Acetate-Mediated IgA Response and Microbiota Restoration.一种强效益生菌通过乙酸介导的IgA反应和微生物群恢复来缓解结肠炎。
J Agric Food Chem. 2023 Feb 14. doi: 10.1021/acs.jafc.2c06697.
7
Biofilm and pathogenic factor analysis of associated with bacterial vaginosis in Northeast China.中国东北地区细菌性阴道病相关生物膜及致病因素分析
Front Microbiol. 2022 Dec 22;13:1033040. doi: 10.3389/fmicb.2022.1033040. eCollection 2022.
8
Antimicrobial Substances and Mechanisms of Lactobacillus rhamnosus against Gardnerella vaginalis.鼠李糖乳杆菌对阴道加德纳菌的抗菌物质及作用机制
Probiotics Antimicrob Proteins. 2023 Apr;15(2):400-410. doi: 10.1007/s12602-022-10019-5. Epub 2022 Dec 2.
9
Lacticaseibacillus rhamnosus Lcr35 Stimulates Epithelial Vaginal Defenses upon Gardnerella vaginalis Infection.罗伊氏乳杆菌 Lcr35 可刺激阴道上皮防御功能以抵御阴道加德纳菌感染
Infect Immun. 2022 Sep 15;90(9):e0030922. doi: 10.1128/iai.00309-22. Epub 2022 Aug 24.
10
Gardnerella vaginalis alters cervicovaginal epithelial cell function through microbe-specific immune responses.阴道加德纳菌通过微生物特异性免疫反应改变宫颈阴道上皮细胞的功能。
Microbiome. 2022 Aug 4;10(1):119. doi: 10.1186/s40168-022-01317-9.